Thus, many studies have used conditional expression of oncogenes such as KRAS or conditional deletion of some key tumor suppressors, such as TP53, Rb, PTEN and BRCA1/2: in all these models, the OSE cell population was targeted by the oncogenic process. The gene discussed is KRAS; the disease is neoplasm.